CINCINNATI, PHILADELPHIA, NEW YORK, SEATTLE – March 01, 2016 – IntegriChain, a rapidly growing cloud software company focused on channel management for life sciences suppliers, today announced that it has received a strategic equity investment from Accel-KKR, a leading technology-focused private equity firm. Under the terms of the investment, Accel-KKR will acquire 100% of the equity not held by members of IntegriChain’s management team.
“With its focus on vertically oriented businesses, Accel-KKR is the ideal partner for IntegriChain, and together we will help life sciences companies maximize patient access to life-improving products,” said Kevin Leininger, co-founder and Chief Executive Officer of IntegriChain. “This partnership validates our growth strategy and will enable us to extend our leadership in delivering solutions that improve life sciences suppliers’ management of their channel relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors.”
“IntegriChain has built a reputation as an innovator and a company that provides a high level of customer service,” said co-founder and Executive Vice President Josh Halpern. “We believe that our partnership with Accel-KKR will benefit both our customers as we continue to innovate and our employees as we continue to grow and thrive.”
“With its industry-leading cloud platform, superior service, and a rapidly growing customer base of top-tier life sciences manufacturers, IntegriChain is a model Accel-KKR investment,” said Fred Sturgis, Managing Director at Accel-KKR. “We look forward to working with the IntegriChain team as they continue to grow and drive innovation in the life sciences channel.”
Needham & Company served as the exclusive financial advisor to IntegriChain on this transaction.
IntegriChain is the leading channel management cloud used by life sciences suppliers, including nine of the top 10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems. By embedding big-data customer insights into daily business processes, IntegriChain helps control the high cost of product distribution while improving product availability, ensuring a higher level of revenue predictability and maximizing distribution investment. More than $200 billion in annual U.S. commerce and two billion transactions flow through the IntegriChain Cloud annually. IntegriChain is backed by Accel-KKR, a leading technology private equity firm. Visit www.integrichain.com to learn more.
About SaaS Capital
SaaS Capital is the premier provider of Committed Credit Facilities to SaaS companies. Focusing exclusively on the SaaS business model, SaaS Capital delivers faster decisions, more capital, and longer commitments. SaaS businesses have used SaaS Capital's Committed Credit Facilities, instead of equity, to finance growth and create hundreds of millions in enterprise value without sacrificing significant ownership or control. Also, through its partnership with DH Capital, a boutique investment banking advisory firm, SaaS Capital can assist with M&A and capital raising services. SaaS Capital has offices in Cincinnati, New York, and Seattle. Visit www.saas-capital.com to learn more.
SaaS Capital offered us the right mix of availability, structure and market expertise to help us bring aggressive product advancements to the market in a timely manner.
CEO, Central Desktop